Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT05970497

Conditions
Cancer, Cutaneous Melanoma, Melanoma, +13 more
Locations
  • UCLA Health Los Angeles, California, United States
  • Mission Dermatology Center Rancho Santa Margarita, California, United States
  • BRCR Global Weston, Florida, United States
  • IU Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
View all 15 locations
View Trial Details
Recruiting

A Study of IBI363 in Subjects With Advanced Melanoma

NCT06081920

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Cancer Hospital & Institute, Beijing, China, Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The Third people's hospital of Zhengzhou Zhengzhou, Henan, China
View Trial Details
Recruiting

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

NCT06965231

Conditions
Acral Melanoma, Melanoma, Melanoma of Skin, +12 more
Locations
  • Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Cancer center, Shanghai 411 hospital, China RongTong Medical Healthcare Group Co.Ltd./411 Hospital, Shanghai University Shanghai, Shanghai Municipality, China
  • Department of Surgical Oncology, Fudan University Shanghai Cancer Center Minhang Branch Hospital Shanghai, Shanghai Municipality, China
  • Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

NCT06797297

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Jishuitan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University Cancer Hospital & Institute, Beijing, China, Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
View all 31 locations
View Trial Details
Recruiting

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

NCT03605771

Conditions
Advanced Cancer, Melanoma, Melanoma Stage III, +12 more
Locations
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Onconogranada Granada, Andalusia, Spain
  • Hospital Universitario Regional de Málaga Málaga, Andalusia, Spain
View all 39 locations
View Trial Details

Related conditions